Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs L Becker

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|December 17, 2008
A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockersMatthijs L Becker, Loes E Visser, Christopher Newton-Cheh, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)functionCornelis Smit, Anne M van Schip, Eric P A van Dongen, et al.
Pharmacogenetics and Genomics|September 28, 2011
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam StudyLaure Elens, Matthijs L Becker, Vincent Haufroid, et al.
European Journal of Clinical Pharmacology|June 12, 2020
Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarolMatthijs L Becker, Renate C A E van Uden, Thijs J Giezen, et al.
International Journal of Medical Informatics|November 12, 2020
Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugsFlorine A Berger, Heleen van der Sijs, T van Gelder, et al.
European Journal of Clinical Pharmacology|February 6, 2026
The phenprocoumon echo: Elevated INR risk after VKA reversal - A retrospective analysis of phenprocoumon and acenocoumarol in clinical practice in a Dutch teaching hospitalEmma M C Tijmensen-Reijers, Soha Saleh, Anita Griffioen-Keijzer, et al.
Journal of Patient Safety|June 26, 2024
Antithrombotic Questionnaire Tool for Evaluation of Combined Antithrombotic Therapy in Community PharmaciesRenate C A E van Uden, Barzo Sulaiman, Patricia A M Pols, et al.
Postgraduate Medical Journal|January 14, 2021
Guidelines for mono, double and triple antithrombotic therapyRenate C A E van Uden, Ilse Houtenbos, Anita Griffioen-Keijzer, et al.
Pharmacogenomics|August 13, 2013
Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam StudyCatherine E de Keyser, Matthijs L Becker, André G Uitterlinden, et al.
Pharmacy (Basel, Switzerland)|May 23, 2023
Implementation of a Patient Questionnaire in Community Pharmacies to Improve Care for Patients Using Combined Antithrombotic Therapy: A Qualitative StudyRenate C A E van Uden, Marit A Bakker, Stephan G L Joosten, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|December 17, 2008
A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockersMatthijs L Becker, Loes E Visser, Christopher Newton-Cheh, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)functionCornelis Smit, Anne M van Schip, Eric P A van Dongen, et al.
Pharmacogenetics and Genomics|September 28, 2011
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam StudyLaure Elens, Matthijs L Becker, Vincent Haufroid, et al.
European Journal of Clinical Pharmacology|June 12, 2020
Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarolMatthijs L Becker, Renate C A E van Uden, Thijs J Giezen, et al.
International Journal of Medical Informatics|November 12, 2020
Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugsFlorine A Berger, Heleen van der Sijs, T van Gelder, et al.
European Journal of Clinical Pharmacology|February 6, 2026
The phenprocoumon echo: Elevated INR risk after VKA reversal - A retrospective analysis of phenprocoumon and acenocoumarol in clinical practice in a Dutch teaching hospitalEmma M C Tijmensen-Reijers, Soha Saleh, Anita Griffioen-Keijzer, et al.
Journal of Patient Safety|June 26, 2024
Antithrombotic Questionnaire Tool for Evaluation of Combined Antithrombotic Therapy in Community PharmaciesRenate C A E van Uden, Barzo Sulaiman, Patricia A M Pols, et al.
Postgraduate Medical Journal|January 14, 2021
Guidelines for mono, double and triple antithrombotic therapyRenate C A E van Uden, Ilse Houtenbos, Anita Griffioen-Keijzer, et al.
Pharmacogenomics|August 13, 2013
Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam StudyCatherine E de Keyser, Matthijs L Becker, André G Uitterlinden, et al.
Pharmacy (Basel, Switzerland)|May 23, 2023
Implementation of a Patient Questionnaire in Community Pharmacies to Improve Care for Patients Using Combined Antithrombotic Therapy: A Qualitative StudyRenate C A E van Uden, Marit A Bakker, Stephan G L Joosten, et al.
Pageof 5